March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Effect of Cannabinoids and MethoxyPolyethylene Glycols on Rat Aqueous Flow Dynamics
Author Affiliations & Notes
  • Abhinav Reddy
    T. R. Lee Center for Ocular Pharmacology, Eastern Virginia Medical School, Virginia Beach, Virginia
  • Sandeep S. Samudre
    T R Lee Ctr for Ocular Pharmacol,
    Eastern Virginia Medical School, Norfolk, Virginia
  • Alireza Hosseini
    Physiological Sciences,
    Eastern Virginia Medical School, Norfolk, Virginia
  • Patricia B. Williams
    TRLee Ctr for Ocular Pharmacol,
    Eastern Virginia Medical School, Norfolk, Virginia
  • Frank A. Lattanzio, Jr.
    Physiological Sciences, Eastern Virginia Medical Sch, Norfolk, Virginia
  • Footnotes
    Commercial Relationships  Abhinav Reddy, None; Sandeep S. Samudre, Lions Eye Institute of Virginia (E); Alireza Hosseini, None; Patricia B. Williams, None; Frank A. Lattanzio, Jr., Inventor (P)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2487. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Abhinav Reddy, Sandeep S. Samudre, Alireza Hosseini, Patricia B. Williams, Frank A. Lattanzio, Jr.; Effect of Cannabinoids and MethoxyPolyethylene Glycols on Rat Aqueous Flow Dynamics. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2487.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Recent studies have demonstrated the efficacy of cannabinoid derivatives and methoxy polyethylene glycols such as MPDTE to reduce intraocular pressure (IOP) and protect retinal ganglionic cells from free radical damage. However, their mechanism of action (MOA) for reducing IOP has not been well studied. This initial study provides insight on their MOA by using a rat model to determine changes in either aqueous humor outflow or aqueous humor production.

Methods: : A Zeiss fluorescent microscope was fitted with a stage and special optics to permit in vivo imaging of the rat anterior chamber using an Olympus DP71 camera. Rats were sedated, baseline images of the anterior chamber were collected and then fluorescein was instilled into the rat’s eyes. Rats were allowed to equilibrate for 30 minutes after which another scan was obtained and rats were promptly treated topically with one of the following agents: saline, 1.0% WIN552122 (WIN), 1.0% MPDTE, 0.1% brimonidine or brinzolamide (n = 4 rats per group). Fluorescence images were then obtained at 30 min intervals for 90 min. Resulting scans were analyzed using Metamorph® Software for fluorescein intensity. Data are presented as mean ± SEM.

Results: : The greatest reduction in intensity was observed after WIN treatment, a reduction of 73±13%. Brimonidine treatment reduced the intensity by 55±10% followed by MPDTE (42±7%) and brinzolamide (39±4%). After saline treatment, fluorescein intensity in the AC after 90 min was reduced by 31±8%.

Conclusions: : Current results suggest that MPDTE like brinzolamide could target aqueous humor production. Similarly, WIN like brimonidine could target aqueous humor outflow. These preliminary results require further experimentation with a larger population of rats to validate the findings. However, this pilot study provides a crucial step forward in elucidating the exact characteristics of WIN and MPDTE MOA.

Keywords: anterior chamber • aqueous • drug toxicity/drug effects 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.